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Abstract
Patients with primary sclerosing cholangitis are at an increased risk of developing cholangiocarcinoma, which is difficult to diagnose because the biliary tree is already distorted. Eleven patients with primary sclerosing cholangitis who underwent orthotopic liver transplantation at this hospital were evaluated. Four patients had coincidental histologically proved cholangiocarcinoma. Patients with cholangiocarcinoma in contrast to patients without tumour presented with rapid onset of persistent jaundice, pruritus, and weight loss associated with an appreciable rise in bilirubin (8X v 2x) and alkaline phosphatase (3.5x v 1.2x) over one year. Cholangiography and computed tomography showed appreciably dilated intrahepatic bile ducts (3/4 v 0/7). The diagnosis of cholangiocarcinoma could only be established before operation in one patient by fine needle aspiration cytology. Tumour was recognised at operation in one other. Histological examination of hepatectomy specimens showed that patients with cholangiocarcinoma had less advanced histological features of primary sclerosing cholangitis. Multiple areas of carcinoembryonic antigen positive epithelial atypia and carcinoma in situ were found in all patients with cholangiocarcinoma. Cholangiocarcinoma recurred in two patients at 14 and 39 months after transplantation. Superimposed cholangiocarcinoma can be predicted in most patients with cholangitis before transplantation, although a definitive diagnosis is difficult to make. Their prognosis after successful transplantation is guarded.
Primary sclerosing cholangitis is a chronic cholestatic disorder of unknown cause characterised by multiple fibrotic strictures of the intra and extrahepatic bile ducts. The rate of progression of the disease is unpredictable, although up Three patients had well or moderately differentiated sclerosing cholangiocarcinoma and one a predominantly intraductal papillary carcinoma. The tumour was located in the common hepatic duct with local invasion into both lobes of the liver in one patient, the common bile duct in one patient, common bile duct and right and left hepatic ducts in one patient, and the common bile duct, common hepatic duct, and adjacent liver in the last patient. All patients showed evidence of extensive intraneural and perineural spread affecting the cut margin of the common bile duct in three patients (including the fourth patient with a small tumour). The portal vein was microscopically involved in two patients. No patient had evidence of nodal spread. All patients had multiple areas of atypical epithelial hyperplasia (dysplasia) and papillary carcinoma in situ at sites remote from the tumour, suggesting a multicentric origin for this tumour. None of the patients with cholangitis only had these features. Dysplastic epithelium, carcinoma in situ, and invasive carcinoma stained positively for carcinoembryonic antigen by immunoperoxidise techniques while normal epithelium was negative (Fig 3) . OUTCOME Three of the 11 patients died of sepsis related complications within the first month of transplantation (two with primary sclerosing cholangitis only, one with primary sclerosing cholangitis and cholangiocarcinoma). The remaining five patients with cholangitis only (71%) were alive from 4-30 months after transplantation. One patient with cholangiocarcinoma died of tumour recurrence 23 months after transplantation while another patient had tumour reccurrence at 39 months. The third patient was tumour free at 14 months.
Discussion
The association of cholangiocarcinoma with ulcerative colitis has been well documented. ' 
